Q-Line Biotech balance sheet is weak and might have solvency issues

Yes, The net debt of Q-Line Biotech is increasing.
Latest net debt of Q-Line Biotech is ₹72.67 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹37.88 Crs.

The profit is oscillating.
The profit of Q-Line Biotech is ₹0 Crs for Mar 2026, ₹0 Crs for Mar 2025 and ₹0 Crs for Mar 2024

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Q-Line Biotech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Accounts Receivable